Skip to main content
SpringerLink
Log in

Inpatient Management of Women with Gestational and Pregestational Diabetes in Pregnancy

  • Hospital Management of Diabetes (G Umpierrez, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

For women with type 1 diabetes (T1DM), type 2 diabetes (T2DM), and gestational diabetes (GDM), poor maternal glycemic control can significantly increase maternal and fetal risk for adverse outcomes. Outpatient medical and nutrition therapy is recommended for all women with diabetes in order to facilitate euglycemia during the antepartum period. Despite intensive outpatient therapy, women with diabetes often require inpatient diabetes management prior to delivery as maternal hyperglycemia can significantly increase neonatal risk of hypoglycemia. Consensus guidelines recommend maternal glucose range of 80–110 mg/dL in labor. The most optimal inpatient strategies for the prevention of hyperglycemia and hypoglycemia proximate to delivery remain unclear and will depend upon factors such as maternal diabetes diagnosis, her baseline insulin resistance, duration and route of delivery etc. Low dose intravenous insulin and dextrose protocols are necessary to achieve optimal predelivery glycemic control for women with T1DM and T2DM. For most with GDM however, euglycemia can be maintained without intravenous insulin. Women treated with a subcutaneous insulin pump during the antepartum period represent a unique challenge to labor and delivery staff. Strategies for self-managed subcutaneous insulin infusion (CSII) use prior to delivery require intensive education and coordination of care with the labor team in order to maintain patient safety. Hospitalization is recommended for most women with diabetes prior to delivery and in the postpartum period despite appropriate outpatient glycemic control. Women with poorly controlled diabetes in any trimester have an increased baseline maternal and fetal risk for adverse outcomes. Common indications for antepartum hospitalization of these women include failed outpatient therapy and/or diabetic ketoacidosis (DKA). Inpatient management of DKA is a significant cause of maternal and fetal morbidity and remains a common indication for hospitalization of the pregnant woman with diabetes. Changes in maternal physiology increase insulin resistance and the risk for DKA. A systematic approach to its management will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 60, March 2005. Pregestational Diabetes Mellitus. Obstet Gynecol. 2005;105:675.

    Article  Google Scholar 

  2. Jovanovic L. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes. Endocr Pract. 2004;10(Suppl):40–5.

    Article  PubMed  Google Scholar 

  3. Mimouni F, Miodovnik M, Siddiqi TA, Khoury J, Tsang RC. Perinatal asphyxia in infants of insulin-dependent diabetic mothers. J Pediatr. 1988;113(2):345

    Google Scholar 

  4. Nold JL, Georgieff MK. Infants of diabetic mothers. Pediatr Clin N Am. 2004;51:619–37.

    Article  Google Scholar 

  5. Hawdon JM. Babies born after diabetes in pregnancy: what are the short- and long-term risks and how can we minimize them? Best Prac Res Clin Obstet Gynecol. 2011;25:91–104. This review characterizes the short-term and long-terms risks for infants born to women with diabetes and identifies those that may potentially be avoided with good antenatal or intrapartum care.

    Article  CAS  Google Scholar 

  6. Andersen O, Hertel L, Schmolker L, et al. Influence of the maternal plasma glucose concentration at delivery on the risk of hypoglycemia in infants of insulin-dependent diabetic mothers. Acta Paediatr Scand. 1985;74:268–73.

    Article  CAS  PubMed  Google Scholar 

  7. Taylor R, Lee C, Kyne-Grzebalski D, Marshall SM, et al. Clinical outcomes of pregnancy in women with type 1 diabetes. Obstet Gynecol. 2002;99:537–41.

    Article  PubMed  Google Scholar 

  8. Balsells M, Corcoy R, Adelantado JM, et al. Gestational diabetes mellitus: metabolic control during labor. Diabetes Nutr Metab. 2000;13:257–62.

    CAS  PubMed  Google Scholar 

  9. Cordero L, Treuer SH, Landon MB, et al. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med. 1998;152(3):249–54.

    Article  CAS  PubMed  Google Scholar 

  10. Kline GA, Edwards A. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: impact on clinically significant neonatal hypoglycemia. Diabetes Res Clin Pract. 2007;77:223–30.

    Article  CAS  PubMed  Google Scholar 

  11. Miodovnik M, Mimouni F, Tsang R, et al. Management of the insulin dependent diabetic during labor and delivery: influences on neonatal outcome. Am J Perinatol. 1987;4:106–14.

    Article  CAS  PubMed  Google Scholar 

  12. West TE, Lowry C. Control of blood glucose during labor in diabetic women with combined glucose and low dose insulin infusion. Br Med J. 1977;1:1252–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Caplan RH, Pagliara AS, Beguin EA, et al. Constant intravenous insulin infusion during labor and delivery in diabetes mellitus. Diabetes Care. 1982;5:6–10.

    Article  CAS  PubMed  Google Scholar 

  14. Feldberg D, Dicker D, Samuel N, et al. Intrapartum management of insulin dependent diabetes mellitus gestatants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump. Acta Obstet Gynecol Scand. 1988;67:333–8.

    CAS  PubMed  Google Scholar 

  15. Garber AJ, Moghissi ES, Bransome Jr ED, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10 Suppl 2:4–9.

    PubMed  Google Scholar 

  16. Barrett HL, Morris J, McElDuff A. Watchful waiting: a management protocol for maternal glycaemia in the peri-partum period. Aust N Z Obstet Gynecol. 2009;49:162–7.

    Article  Google Scholar 

  17. Carron Brown S, Kyne-Grzebalski D, Mwangi B, et al. Effect of management policy upon 120 Type 1 diabetic pregnancies: policy decisions in practice. Diabetes Med. 1999;16:573–8.

    Article  CAS  Google Scholar 

  18. Conway DL, Catalano PM, et al. In: Kitzmiller JL, Jovanovic L, Brown F, editors. Management of delivery. In: managing Pre-existing diabetes and pregnancy. Technical reviews and consensus recommendations for care. Alexandria: American Diabetes Association; 2008. p. 584.

    Google Scholar 

  19. Flores-Le roux JA, Chillaron JJ, Goday A, et al. Peripartum control in gestational diabetes. Am J Obstet Gynecol. 2010;202(568):e1–6. The results of this prospective observation study determined that only 31 % of women with GDM required insulin during labor. For women with GDM and intrapartum glucose values within target range, the risk of neonatal hypoglycemia was significantly associated with antepartum A1C and limited prenatal care.

    PubMed  Google Scholar 

  20. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Prac. 2004;10 Suppl 2:71–80.

    Article  Google Scholar 

  21. White NH, Skor D, Santiago JV. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med. 1982;97:210–3.

    Article  CAS  PubMed  Google Scholar 

  22. Boord JB, Sharifi M, Greevy RA, et al. Computer-based insulin infusion protocol improves glycemia control over manual protocol. J Am Med Inform Assoc. 2007;14:278–87.

    Article  PubMed Central  PubMed  Google Scholar 

  23. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;98:525–38.

    Google Scholar 

  24. Lean ME, Pearson DW, Sutherland HW. Insulin management during labor and delivery in mothers with diabetes. Diabetes Med. 1990;7:162–4.

    Article  CAS  Google Scholar 

  25. Njenga E, Lind T, Taylor R. Five year audit of peri-partum blood glucose control in type 1 diabetic patients. Diabetes Med. 1992;9:567–70.

    Article  CAS  Google Scholar 

  26. Rosenberg VA, Eglinton GS, Rauch ER, et al. Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am J Obstet Gynecol. 2006;195:1095–9.

    Article  CAS  PubMed  Google Scholar 

  27. Rosenn BM, Miodovnik M. Glycemic control in the diabetic pregnancy: is tighter control always better? J Mat Fetal Med. 2000;9:29–34.

    CAS  Google Scholar 

  28. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab. 2013;98:1845–59. This report confirms working definition of hypoglycemia, describes implications of hypoglycemia on treatment outcomes, and presents strategies for prevention.

    Article  CAS  PubMed  Google Scholar 

  29. Gabbe SG, Carpneter LB, Garrison EA. New strategies for glucose control in patients with Type 1 and Type 2 Diabetes Mellitus in pregnancy. Clin Obstet Gynecol. 2007;50:1014–24.

    Article  PubMed  Google Scholar 

  30. Mazze R, Yogev Y, Langer O. Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy. J Matern Fetal Neonatal Med. 2012;7:1171–5.

    Article  Google Scholar 

  31. Fresa R, Visalli N, Di Bassi V, et al. Experiences of continuous subcutaneous insulin infusion in pregnant women with Type 1 Diabetes during delivery from four Italian Centers: a retrospective observational study. Diabetes Tech Ther. 2013;15:328–34.

    Article  CAS  Google Scholar 

  32. Gabbe SG. New concepts and applications in the use of the insulin pump during pregnancy. J Matern Fetal Med. 2000;9:42–5.

    CAS  PubMed  Google Scholar 

  33. McCrea D. Management of the hospitalized diabetes patient with an insulin pump. Crit Care Nur Clin N Am. 2013;25:111–21.

    Article  Google Scholar 

  34. Leonhardi BJ, Boyle ME, Beer KA, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: a review of one institution’s experience. J Diabetes Sci Technol. 2008;2:948–62.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Nassar AA, Partlow BJ, Boyle ME, et al. Outpatient-to-inpatient transition of insulin pump therapy: successes and continuing challenges. J Diabetes Sci Tech. 2010;4:863–72.

    Article  Google Scholar 

  36. Cook CB, Boyle ME, Cisar NS, et al. Proposed guidelines and outcome measures use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting : proposed guidelines and outcomes measures. Diabetes Educ. 2005;31:849–57.

    Article  PubMed  Google Scholar 

  37. The American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient metabolic control. Endocr Prac. 2004;10:77–82.

    Article  Google Scholar 

  38. Kjos SL. After pregnancy complicated by diabetes: postpartum care and education. Obstet Gynecol Clin N Am. 2007;34:335–49.

    Article  Google Scholar 

  39. American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36 Suppl 1:S11–66. Provides evidence based consensus recommendations for the diagnosis, screening, and management of diabetes in adults and in special populations including GDM.

    Article  Google Scholar 

  40. Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol. 2007;50:938–48.

    Google Scholar 

  41. Quinn SL, Lansang MC, Mina D. Safety and effectiveness of U-500 insulin therapy in patients with insulin resistant type 2 diabetes mellitus. Pharmacotherapy. 2011;31:695–702.

    Article  CAS  PubMed  Google Scholar 

  42. U.S. Food and Drug Administration. Potential signals of serious risks/new safety information identified from the adverse event reporting system (AERS) between January– March, 2008. Available from http://www.fda.gov/Drugs/GuidanceCompliance RegulatoryInformation/ Surveillance/ Adverse Drug Effects/ ucm08 5914.htm. Accessed October 6, 2008.

  43. Reutrakal S, Wroblewski K, Brown RL. Clinical use of U-500 regular insulin: review and meta- analysis. J Diabetes Sci Tech. 2012;6(2):412–20. This meta-analysis of characterizes the efficacy and risks reported with U-500 use in 365 adults with Type 1 and Type 2 diabetes complicated by severe insulin resistance.

    Article  Google Scholar 

  44. De la Pena A, Riddle M, Morrow LA, et al. Pharmacokinetics and pharmacodynamics of high dose regular human insulin in healthy obese subjects. Diabetes Care. 2011;34:2496–2501.

    Article  PubMed  Google Scholar 

  45. Daily AM, Williams S, Tajeha D, Tannock LR. Clinical evidence with U-500 insulin use. Diabetes Res Clin Pract. 2010;88:259–64.

    Article  Google Scholar 

  46. Zuckerwise LC, Werner EF, Pettker CM, et al. Pregestational diabetes with extreme insulin resistance. Use of U-500 in pregnancy. Obstet Gynecol. 2012;12:439–42.

    Article  Google Scholar 

  47. Okeigwe I, Yeaton-Massey A, Kim S, et al. U-500R and aspart insulin for the treatment of severe insulin resistance associated with pregestational diabetes. J Perinatol. 2013;33:235–8.

    Article  CAS  PubMed  Google Scholar 

  48. Reece EA. Use of U-500 Insulin in pregnancy is intriguing, but controlled trials are needed. Obstet Gynecol. 2012;120(Part 2):435–6.

    CAS  PubMed  Google Scholar 

  49. Samaan KH, Dahlke M, Stover J. Addressing safety concerns about u-500 insulin in a hospital setting. Am J Health Syst Pharm. 2011;68:63–8.

    Article  PubMed  Google Scholar 

  50. Garg R, Johsn V, McNally PG, et al. U-500 Insulin: why, when, how to use in clinical practice. Diabetes Metab Res Rev. 2007;23:265–8.

    Article  CAS  PubMed  Google Scholar 

  51. Segal AR, Brunner JE, Burch FT. Use of concentrated insulin human regular (U-500) for patients with diabetes. Am J Health Syst Pharm. 2010;67:1526–35.

    Article  CAS  PubMed  Google Scholar 

  52. Shubrook JH. Insulin therapy for challening patient cases. J Am Osteopath. 2013;113(4 Suppl 2):217–28.

    Google Scholar 

  53. Cullen MT, Reece EA, Homko CJ, et al. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Perinatol. 1996;13(7):449–52.

    Article  CAS  PubMed  Google Scholar 

  54. Montoro MN, Meyer VP, Mestman JH, et al. Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol. 1993;10:17–20.

    Article  CAS  PubMed  Google Scholar 

  55. Hagay ZJ. Diabetic ketoacidosis in pregnancy: etiology, pathophysiology, and management. Clin Obstet Gynecol. 1994;37:50–68.

    Article  Google Scholar 

  56. Rogers BD, Rogers DE. Clinical variables associated with diabetic ketoacidosis during pregnancy. J Reprod Med. 1991;36:797–9.

    Google Scholar 

  57. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin N Am. 1999;26:481–8.

    Article  CAS  Google Scholar 

  58. Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Crit Care Med. 2005;33:S347–53.

    Article  PubMed  Google Scholar 

  59. Schenider MB, Umiperrez GE, Ramsey RD, et al. Pregnancy complicated by diabetic ketoacidosis. Diabetes Care. 2003;26:958–9.

    Article  Google Scholar 

  60. Kitabachi AE, Umiperrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24:131–53.

    Article  Google Scholar 

  61. Umiperrez GE, Muphy MB, Kitabchi AE, et al. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Diabetes Spectr. 2002;15:28–36.

    Article  Google Scholar 

  62. Parker JA, Conwat DL. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin N Am. 2007;34:533–43.

    Article  Google Scholar 

  63. Clark JD, McConnell A, Hartog M. Normoglycemic ketoacidosis in a woman with gestational diabetes. Diabetes Med. 1991;8:388–9.

    Article  CAS  Google Scholar 

  64. Franke B, Carr D, Hatem MH. A case of euglycemic diabetic ketoacidosis in pregnancy. Diabetes Med. 2001;18:858–9.

    Article  CAS  Google Scholar 

  65. Chico M, Levine SN, Lewis DF. Normoglycemic diabetic ketoacidosis in pregnancy. J Perinatol. 2008;28:310–2.

    Article  CAS  PubMed  Google Scholar 

  66. Kilvert JA, Nicholson HO, Wright AD. Ketoacidosis in diabetic pregnancy. Diabetes Med. 1993;10:278–81.

    Article  CAS  Google Scholar 

  67. Kamalakannan D, Baskar V, Barton DM, et al. Diabetic ketoacidosis in pregnancy. Postgrad Med J. 2003;79:454–7.

    Article  CAS  PubMed  Google Scholar 

  68. Lindenbaum C, Menzin A, Ludmir J. Diabetic ketoacidosis in pregnancy resulting from insulin pump failure. A case report. L Reprod Med. 1993;38:306–8.

    CAS  Google Scholar 

  69. Chauhan SP, Perry KG, McLaughlin BN, et al. Diabetic ketoacidosis complicating pregnancy. J Perinatol. 1996;16:173–5.

    CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Etoi A. Garrison declares that he has no conflict of interest. Shubhada Jagasia declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Vanderbilt University Medical Center, 8210 Medical Center East South Tower, 1215 21st Avenue South, Nashville, TN, 37232-8148, USA

    Etoi A. Garrison & Shubhada Jagasia

Authors
  1. Etoi A. Garrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shubhada Jagasia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shubhada Jagasia.

Additional information

This article is part of the Topical Collection on Hospital Management of Diabetes

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garrison, E.A., Jagasia, S. Inpatient Management of Women with Gestational and Pregestational Diabetes in Pregnancy. Curr Diab Rep 14, 457 (2014). https://doi.org/10.1007/s11892-013-0457-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-013-0457-x

Keywords

Search

Navigation